Does smoking affect the prevalence of caffeine use in schizophrenia?
Introduction Caffeine acts as a competing antagonist of adenosine receptors, increasing the release of norepinephrine and the activation of noradrenergic neurons. Long-standing schizophrenia patients frequently develop a comorbidly high daily caffeine intake. This could be explained by its relation...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cambridge University Press
2022-06-01
|
| Col·lecció: | European Psychiatry |
| Matèries: | |
| Accés en línia: | https://www.cambridge.org/core/product/identifier/S0924933822020065/type/journal_article |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|